Literature DB >> 9751188

Hypoxic cell death in human NT2-N neurons: involvement of NMDA and non-NMDA glutamate receptors.

T Rootwelt1, M Dunn, M Yudkoff, T Itoh, R Almaas, D Pleasure.   

Abstract

Human NTera2 teratocarcinoma cells were differentiated into postmitotic NT2-N neurons and exposed to hypoxia for 6 h. The cultures were evaluated microscopically, and percent lactate dehydrogenase (LDH) release after 24 and 48 h was used as an assay for cell death. After 48 h LDH release was 24.3 +/- 5.6% versus 13.8 +/- 3.7% in controls (p < 0.001). Cell death was greatly diminished by MK-801 pretreatment (15.4 +/- 5.1%, p < 0.001). If glutamine was omitted from the medium, glutamate levels after 6 h of hypoxia were reduced from 101 +/- 63 to 2.3 +/- 0.3 microM, and cell death at 48 h was also markedly reduced (15.4 +/- 4.5%, p < 0.001). The alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (18.7 +/- 5.1%, p < 0.001) and mild hypothermia (33.5-34 degrees C) during hypoxia (19.5 +/- 2.7%, p < 0.05) were moderately protective. Basic fibroblast growth factor (24.1 +/- 3.2%), the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester (22.8 +/- 8.1%), the antioxidant N-tert-butyl-o-phenyinitrone (18.9 +/- 5.9%), and the 21-aminosteroid U74389G (24.0 +/- 3.4%) did not protect the cells. N-Acetyl-L-cysteine even tended to increase cell death (30.1 +/- 2.5%, p = 0.06). Treatment with MK-801 at the end of hypoxia did not reduce cell death (23.3 +/- 2.3%). In separate experiments, a 15-min exposure to 1 mM glutamate without hypoxia did not result in significant cell death (14.7 +/- 2.4 vs. 12.2 +/- 2.1%, p = 0.07). We conclude that, although somewhat resistant to glutamate toxicity when normoxic, NT2-N neurons die via an ionotropic glutamate receptor-mediated mechanism when exposed to hypoxia in the presence of glutamate. As far as we know, this is the first reported analysis of the mechanism of hypoxic cell death in cultured human neuronlike cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751188     DOI: 10.1046/j.1471-4159.1998.71041544.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Neuroprotection of cerebrolysin in tissue culture models of brain ischemia: post lesion application indicates a wide therapeutic window.

Authors:  E Schauer; R Wronski; J Patockova; H Moessler; E Doppler; B Hutter-Paier; M Windisch
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

2.  Cross talk between increased intracellular zinc (Zn2+) and accumulation of reactive oxygen species in chemical ischemia.

Authors:  Kira G Slepchenko; Qiping Lu; Yang V Li
Journal:  Am J Physiol Cell Physiol       Date:  2017-07-26       Impact factor: 4.249

3.  Activation of Toll-like receptors inhibits herpes simplex virus-1 infection of human neuronal cells.

Authors:  Yu Zhou; Li Ye; Qi Wan; Lin Zhou; Xu Wang; Jieliang Li; Shuxian Hu; Dunjin Zhou; Wenzhe Ho
Journal:  J Neurosci Res       Date:  2009-10       Impact factor: 4.164

4.  Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathway.

Authors:  Wei Chen; Jerrold Sulcove; Ian Frank; Salman Jaffer; Hakan Ozdener; Dennis L Kolson
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  Hypothermia protects human neurons.

Authors:  Ana Antonic; Mirella Dottori; Jessie Leung; Kate Sidon; Peter E Batchelor; William Wilson; Malcolm R Macleod; David W Howells
Journal:  Int J Stroke       Date:  2014-01-03       Impact factor: 5.266

6.  Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro.

Authors:  Susann Hau; Doreen M Reich; Markus Scholz; Wilfried Naumann; Frank Emmrich; Manja Kamprad; Johannes Boltze
Journal:  BMC Neurosci       Date:  2008-02-29       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.